SIMBRINZA (brinzolamide/brimonidine tartrate)

**Product type:** Human Prescription Drug

**Active ingredient:** BRIMONIDINE TARTRATE; BRINZOLAMIDE

**Strength:** 2; 10 mg/mL; mg/mL

**Dosage form:** Suspension/ Drops

**Route:** Ophthalmic

**Labeler:** Alcon Laboratories, Inc.

**Marketing category:** NDA (NDA204251)

**Pharmacologic class:** Adrenergic alpha-Agonists [MoA], Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], alpha-Adrenergic Agonist [EPC]